ELUCID

elucid-logo

Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.

#SimilarOrganizations #People #Financial #Event #Website #More

ELUCID

Social Links:

Industry:
Analytics Biotechnology Medical Device

Founded:
2013-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.elucid.com

Total Employee:
51+

Status:
Active

Contact:
617-329-9487

Email Addresses:
[email protected]

Total Funding:
49.73 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud COVID-19 DMARC Shutterstock


Similar Organizations

enlitic-logo

Enlitic

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

gelesis-logo

Gelesis

Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.

spero-therapeutics-logo

Spero Therapeutics

Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.

Current Employees Featured

andrew-j-buckler_image

Andrew J. Buckler
Andrew J. Buckler President and CTO @ Elucid
President and CTO

jason-bottiglieri_image

Jason Bottiglieri
Jason Bottiglieri CCO @ Elucid
CCO
2020-10-01

joins-elucid_image

Joins Elucid
Joins Elucid Chief Medical Officer @ Elucid
Chief Medical Officer
2022-07-01

blake-richards_image

Blake Richards
Blake Richards CEO @ Elucid
CEO

Founder


andrew-j-buckler_image

Andrew J. Buckler

Investors List

iag-capital-partners_image

IAG Capital Partners

IAG Capital Partners investment in Series B - Elucid

aphelion-capital_image

Aphelion Capital

Aphelion Capital investment in Series B - Elucid

bold-brain-ventures_image

Bold Brain Ventures

Bold Brain Ventures investment in Series B - Elucid

biovision-ventures_image

Biovision Ventures

Biovision Ventures investment in Series B - Elucid

bluestone-venture-partners_image

BlueStone Venture Partners

BlueStone Venture Partners investment in Series B - Elucid

medtex-ventures_image

MedTex Ventures

MedTex Ventures investment in Series B - Elucid

medtex-ventures_image

MedTex Ventures

MedTex Ventures investment in Series A - Elucid

wolverine-venture-fund_image

Wolverine Venture Fund

Wolverine Venture Fund investment in Series A - Elucid

iag-capital-partners_image

IAG Capital Partners

IAG Capital Partners investment in Series A - Elucid

global-health-impact-fund_image

Global Health Impact Fund

Global Health Impact Fund investment in Series A - Elucid

Key Employee Changes

Date New article
2022-07-26 Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer

Official Site Inspections

http://www.elucid.com Semrush global rank: 4.86 M Semrush visits lastest month: 1.82 K

  • Host name: 141.193.213.11
  • IP address: 141.193.213.11
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Elucid" on Search Engine